The arrival of Retatrutide ZPHC, at a concentration of 120mg, is generating considerable buzz within the weight loss community. This groundbreaking dual GIP and GLP-1 agonist medication seems to offer significant improvements in fat loss compared to existing therapies. Preliminary research trials